Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

Site for A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients with Low Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence

This Phase 3, multinational, single-arm, multicenter study will evaluate the efficacy and safety of UGN-102 as primary chemoablative therapy in patients with LG IR NMIBC.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT05243550
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Low Grade Bladder Cancer
Requiring treatment with TURBT
Multiple tumors
Tumor >3cm
Tumor recurrence within 1 year
Exclusion Criteria:
Received BCG within previous 1 year
History of High Grade bladder Cancer in past 2 years
Sensitivity to mitomycin
Neurogenic bladder
Significant urethral stricture precluding passage of urethral catheter
Cancer
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA